Nuvectra Corporation (NASDAQ:NVTR) Releases Earnings Results, Beats Expectations By $0.07 EPS

Nuvectra Corporation (NASDAQ:NVTR) released its quarterly earnings results on Tuesday, August 8th. The company reported ($1.07) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($1.14) by $0.07, Briefing.com reports. Nuvectra Corporation had a negative net margin of 232.31% and a negative return on equity of 56.68%. The business had revenue of $7.20 million for the quarter, compared to the consensus estimate of $5.96 million. During the same period last year, the firm earned ($0.85) earnings per share. The company’s quarterly revenue was up 188.0% on a year-over-year basis.

Shares of Nuvectra Corporation (NASDAQ NVTR) opened at 11.41 on Friday. Nuvectra Corporation has a 52 week low of $4.63 and a 52 week high of $15.00. The stock’s market capitalization is $122.08 million. The stock has a 50 day moving average of $12.17 and a 200-day moving average of $9.40.

Several research firms have weighed in on NVTR. B. Riley reiterated a “buy” rating and issued a $12.00 price target on shares of Nuvectra Corporation in a research report on Wednesday, May 10th. Zacks Investment Research upgraded shares of Nuvectra Corporation from a “sell” rating to a “hold” rating in a research report on Wednesday, July 12th. Piper Jaffray Companies reiterated a “neutral” rating and issued a $14.00 price target on shares of Nuvectra Corporation in a research report on Thursday, July 6th. TheStreet raised shares of Nuvectra Corporation from a “d” rating to a “c-” rating in a research note on Monday, June 19th. Finally, ValuEngine raised shares of Nuvectra Corporation from a “sell” rating to a “hold” rating in a research note on Friday, June 16th. Three analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. Nuvectra Corporation presently has an average rating of “Hold” and an average price target of $10.50.

In related news, CEO Scott F. Drees acquired 10,000 shares of Nuvectra Corporation stock in a transaction on Friday, August 11th. The stock was bought at an average cost of $11.72 per share, for a total transaction of $117,200.00. Following the completion of the transaction, the chief executive officer now owns 125,180 shares of the company’s stock, valued at approximately $1,467,109.60. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Scott F. Drees acquired 7,395 shares of Nuvectra Corporation stock in a transaction on Tuesday, May 30th. The shares were bought at an average price of $10.41 per share, with a total value of $76,981.95. Following the completion of the transaction, the chief executive officer now directly owns 99,136 shares of the company’s stock, valued at approximately $1,032,005.76. The disclosure for this purchase can be found here. Insiders have acquired 20,000 shares of company stock valued at $220,024 over the last 90 days.

ILLEGAL ACTIVITY NOTICE: This piece was published by Community Financial News and is the sole property of of Community Financial News. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright law. The correct version of this piece can be accessed at https://www.com-unik.info/2017/08/19/nuvectra-corporation-nasdaqnvtr-posts-earnings-results-beats-expectations-by-0-07-eps-updated.html.

Nuvectra Corporation Company Profile

Nuvectra Corporation is a neurostimulation company that focuses on helping physicians to improve the lives of people with chronic neurological conditions. The Company’s Algovita Spinal Cord Stimulation (SCS) System (Algovita) is the Company’s commercial offering and is Conformite Europeene (CE) marked and the United States Food and Drug Administration (FDA) approved for the treatment of chronic pain of the trunk and/or limbs.

Earnings History for Nuvectra Corporation (NASDAQ:NVTR)

What are top analysts saying about Nuvectra Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Nuvectra Corporation and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit